n(omega)-hydroxyarginine has been researched along with pyrrolidine-2,4-dicarboxylic acid in 1 studies
Studies (n(omega)-hydroxyarginine) | Trials (n(omega)-hydroxyarginine) | Recent Studies (post-2010) (n(omega)-hydroxyarginine) | Studies (pyrrolidine-2,4-dicarboxylic acid) | Trials (pyrrolidine-2,4-dicarboxylic acid) | Recent Studies (post-2010) (pyrrolidine-2,4-dicarboxylic acid) |
---|---|---|---|---|---|
139 | 0 | 24 | 190 | 0 | 16 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Galloway, MP; West, AR | 1 |
1 other study(ies) available for n(omega)-hydroxyarginine and pyrrolidine-2,4-dicarboxylic acid
Article | Year |
---|---|
Inhibition of glutamate reuptake potentiates endogenous nitric oxide-facilitated dopamine efflux in the rat striatum: an in vivo microdialysis study.
Topics: Animals; Arginine; Corpus Striatum; Dicarboxylic Acids; Dopamine; Glutamic Acid; Infusions, Parenteral; Kinetics; Male; Microdialysis; Neurotransmitter Uptake Inhibitors; Nitric Oxide; Pyrrolidines; Rats; Rats, Sprague-Dawley | 1997 |